跳至主要内容
临床试验/NCT04053335
NCT04053335已完成不适用

Eliminating Low-Value Care in Virginia: Six Large Health Systems

University of California, Los Angeles1 个研究点 分布在 1 个国家目标入组 5,000,000 人开始时间: 2019年7月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
5,000,000
试验地点
1
主要终点
Percentage of participants with low-value utilization across the 9 low-value care measures

研究概览

简要总结

Low-value care is defined as patient care that provides no net benefit to patients in specific clinical scenarios, and can cause patient harm. Prior research has documented high-rates of low-value care in Virginia; this work has helped to inspire a Virginia government-sponsored quality improvement initiative to reduce low-value care. Funded by an Arnold Ventures grant, six large health systems in Virginia volunteered to partner with the Virginia Center for Health Innovation (VCHI) to reduce use of nine low-value health services (three preoperative testing measures, two cardiac screening measures, one diagnostic eye imaging measure, one low-back pain opioid measure, one low-back pain imaging measure and one peripherally inserted central catheter [PICC] measure). These health systems include nearly 7000 clinicians practicing across more than 1000 sites.

VCHI is implementing a nonrandomized physician peer-comparison feedback quality improvement intervention to reduce use of nine low-value services. Modeling will be used to identify and use propensity score matching to match six intervention health systems to six comparable control health systems. VCHI will provide education, quality improvement training and financial resources to each site, and VCHI will use the Milliman MedInsight Health Waste Calculator to create the peer comparison reports using the Virginia All Payer Claims Database (APCD). VCHI will use additional measures from The Agency for Healthcare Research and Quality (AHRQ). Additionally, VCHI will use AHRQ data to attribute physicians and health care facilities to health systems.

The primary purpose of the initiative is to improve quality of care for Virginia residents and this initiative is not being done for research purposes. Nevertheless, University of California, Los Angeles (UCLA) plans to rigorously study and publish the impact of this intervention across the state of Virginia, which is why the UCLA team pre-registered the initiative. The UCLA team will use the Virginia APCD to evaluate the impact of the intervention. Please note: the APCD has a 1-year time-lag of data collection and is a dynamic database, meaning that its population of enrollees changes from year to year. This intervention was initially designed as a randomized step-wedge intervention; the intervention was delayed by the COVID-19 pandemic and began in September 2020 for all intervention groups. The intervention period was extended through December 2022. As a result, the initial design was modified.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Percentage of participants with low-value utilization across the 9 low-value care measures

时间窗: 36 months

Measures defined using evidence-based guidelines such as the USPSTF, American College of Cardiology, Choosing Wisely and others. The primary measure is global percentage of use among eligible patients across 9 measures (see eligibility criteria for measure-specific denominators): * Preoperative laboratory testing * Preoperative EKGs, chest x-rays and pulmonary function testing * Preoperative cardiac imaging/stress testing * Annual EKG/other cardiac screening for low-risk adults * Cardiac stress imaging/cardiac imaging in low-risk adults * Diagnostic eye imaging in low-risk patients * Peripherally inserted central catheters in stage 3-5 chronic kidney disease patients without nephrology consult * Opioid prescribing for low back pain (added Jan 2022) * Imaging for nonspecific low back pain (added Jan 2022) UCLA statisticians will independently assess measures using the Virginia APCD, which includes paid claims for Commercial, Medicaid, and Medicare insured patients

次要结局

  • Percentage participants with high-value utilization across the 9 measures (e.g., balancing measures)(36 months)
  • Percentage of participants with adverse events (e.g., peri-operative medical complications)(36 months)
  • Reduction in low- and high-value services by socioeconomic status(36 months)
  • Total costs (estimates from percent effort of clinical leadership team, utilization trends(36 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

John N. Mafi, MD, MPH

Principal Investigator

University of California, Los Angeles

研究点 (1)

Loading locations...

相似试验